The Ministry of Justice has not set a target waiting time for benefit appeals to be heard in the Social Security and Child Support (SSCS) jurisdiction. This is because waiting times fluctuate geographically owing to a number of factors including venue capacity, the volumes of benefit decisions made locally, the complexity of the case and the availability of panel members. Furthermore, the listing of appeals, including consideration of whether a hearing should be expedited, is a function of the Tribunal\u2019s judiciary. There are also no targets for staffing levels for medical members, disability qualified members or judges in the SSCS jurisdiction. Levels are set based on forecast receipts to the SSCS jurisdiction, outstanding workload, and venue capacity.<\/p>
<\/p>
HM Courts and Tribunals Service (HCMTS) is taking positive steps to reduce the waiting time for appeals to be heard in the SSCS jurisdiction. In 2018, 232 medical members and 118 disability-qualified members were additionally appointed to the SSCS jurisdiction and an extra 129 fee-paid judges have recently been appointed. The SSCS jurisdiction will also benefit from 100 salaried judges and 170 fee-paid judges being recruited across tribunals more widely. In addition, HMCTS is developing a new digital system with a view to enabling speedier processing of appeals and a better service for all parties to the proceedings. Case-management \u201ctriage\u201d sessions are also being conducted, with the aim of reducing the number of cases that need to progress to an oral hearing.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3926", "label" : {"_value" : "Biography information for Paul Maynard"} } , "answeringMemberConstituency" : {"_value" : "Blackpool North and Cleveleys"} , "answeringMemberPrinted" : {"_value" : "Paul Maynard"} , "dateOfAnswer" : {"_value" : "2019-07-17", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "274534"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-17T17:10:49.07Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "54"} , "answeringDeptShortName" : {"_value" : "Justice"} , "answeringDeptSortName" : {"_value" : "Justice"} , "date" : {"_value" : "2019-07-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Social Security Benefits: Appeals"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Justice, pursuant to the Answer of 19 February to Question 221635, what the target staffing levels are for (a) medical members, (b) disability qualified members and (c) judges in the social security and child support jurisdiction.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mary Glindon"} ], "uin" : "274535"} , {"_about" : "http://data.parliament.uk/resources/1137076", "AnsweringBody" : [{"_value" : "Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1137076/answer", "answerText" : {"_value" : "
The treatment of infrastructure investment by insurance undertakings for the purposes of prudential regulation is set by the Solvency II Directive. In March 2019, the EU adopted new Solvency II rules to help insurers to invest in equity and private debt and to provide long-term capital financing. This means that insurers will be able to hold less capital for such investments and will therefore find such investments more attractive. The Government does not collect information about such investments, but individual insurance firms often include such details in their annual reports.<\/p>
<\/em><\/p>The government provides competitive R&D tax reliefs to support businesses to invest. Support for businesses through R&D tax reliefs rose to £3.7 billion in 2015-16, up by almost a quarter from the previous year. The government is also carrying out the Infrastructure Finance Review, to support private infrastructure investment and ensure that infrastructure projects, including those using new technologies, are able to access the finance they need. The review will conclude alongside the National Infrastructure Strategy in the Autumn. <\/p>In 2018, the UK Government provided £20m of \u2018pioneer funding\u2019 through the Next Generation Services Industrial Strategy Challenge Fund to explore how new technologies could transform the UK accountancy, insurance and legal services industries <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/57", "label" : {"_value" : "Biography information for Lord Young of Cookham"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Young of Cookham"}
, "dateOfAnswer" : {"_value" : "2019-07-17", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-17T16:31:26.07Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "14"}
, "answeringDeptShortName" : {"_value" : "Treasury"}
, "answeringDeptSortName" : {"_value" : "Treasury"}
, "date" : {"_value" : "2019-07-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Insurance Companies: Investment"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what steps they are taking to promote investment by the insurance industry into applied research, new technologies, and infrastructure; whether information about any such investments will be published on an annual basis; and if so, where.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/2543", "label" : {"_value" : "Biography information for Lord Hunt of Chesterton"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Chesterton"}
], "uin" : "HL16940"}
, {"_about" : "http://data.parliament.uk/resources/1136781", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1136781/answer", "answerText" : {"_value" : " The Department-designated Academic Health Science Centres (AHSCs) along with the Academic Health Science Networks (AHSNs) and the National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs) are all important components of the country\u2019s health research and innovation ecosystem.<\/p> The six current Department-designated AHSCs were made on the basis of an open competition, which was open to eligible National Health Service and University partnerships across England. The recommendations for designation were made to the Department by an international independent panel.<\/p> The remit of the Accelerated Access Collaborative (AAC) has recently been expanded to become the umbrella body across the United Kingdom health innovation eco-system. The AAC has been asked to consider the role of new AHSCs within the health system and to ensure that they complement the innovation landscape, rather than add further complexity to it.<\/p> It is not possible to provide specific details of the scope and nature of the new designation process at this stage given that the AAC is currently actively considering this. However, it is expected that the future designation process would be open to all NHS and University partnerships across England which meet the published specification to apply, including partnerships in areas of England where there is currently no Departmental-AHSC. As with the previous AHSC designation process, any future process will be run via a full and open competition, assessed by an independent expert panel. Rigorous conflict of interest policies will also be in place throughout the process for all involved to ensure any potential conflicts are dealt with appropriately.<\/p> The existing Departmental-AHSC designation will be extended until the end of March 2020 to enable a new designation process to be undertaken. The Department\u2019s expectation is that AHSCs will play an increasingly important role in the health innovation and research landscape over the coming years.<\/p> As currently, the success of any newly designated AHSCs will require close interplay and cooperation between research infrastructure, including NIHR Biomedical Research Centres (BRCs) and the NIHR ARCs, and with the AHSNs and wider innovation landscape.<\/p> As part of annual monitoring of the existing Department-designated AHSCs, examples of innovations arising from them have been reported to have been made available to patients in the NHS. These include:<\/p> - The King\u2019s Health Partners Heart Failure Service, which brings together clinical, research and educational expertise to deliver world class heart care in south London, helping people with heart failure live longer and with better quality of life;<\/p> - University College London Partners AHSC adoption of a Learning Health System to standardise data entry and allowing the widespread trialling of novel tools to detect atrial fibrillation early;<\/p> - The Manchester AHSC working with partners to align research around core health and social care priorities; and supporting the roll out of a single blood test driven decision-aid for patients presenting with chest pain at local emergency departments; and<\/p> - The roll out of the innovative Sleepio app by the Oxford AHSN to support those suffering from insomnia across Oxfordshire, Berkshire and Buckinghamshire.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
, "dateOfAnswer" : {"_value" : "2019-07-17", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL16932"}
, {"_value" : "HL16934"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-17T16:29:08.16Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Academic Health Science Networks"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government by what process, during the current development of policy options for Academic Health Science Centres (AHSC), potential new AHSCs can be considered in areas of England currently unrepresented by existing AHSCs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4151", "label" : {"_value" : "Biography information for Lord Willis of Knaresborough"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Willis of Knaresborough"}
], "uin" : "HL16931"}
, {"_about" : "http://data.parliament.uk/resources/1136782", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1136782/answer", "answerText" : {"_value" : " The Department-designated Academic Health Science Centres (AHSCs) along with the Academic Health Science Networks (AHSNs) and the National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs) are all important components of the country\u2019s health research and innovation ecosystem.<\/p> The six current Department-designated AHSCs were made on the basis of an open competition, which was open to eligible National Health Service and University partnerships across England. The recommendations for designation were made to the Department by an international independent panel.<\/p> The remit of the Accelerated Access Collaborative (AAC) has recently been expanded to become the umbrella body across the United Kingdom health innovation eco-system. The AAC has been asked to consider the role of new AHSCs within the health system and to ensure that they complement the innovation landscape, rather than add further complexity to it.<\/p> It is not possible to provide specific details of the scope and nature of the new designation process at this stage given that the AAC is currently actively considering this. However, it is expected that the future designation process would be open to all NHS and University partnerships across England which meet the published specification to apply, including partnerships in areas of England where there is currently no Departmental-AHSC. As with the previous AHSC designation process, any future process will be run via a full and open competition, assessed by an independent expert panel. Rigorous conflict of interest policies will also be in place throughout the process for all involved to ensure any potential conflicts are dealt with appropriately.<\/p> The existing Departmental-AHSC designation will be extended until the end of March 2020 to enable a new designation process to be undertaken. The Department\u2019s expectation is that AHSCs will play an increasingly important role in the health innovation and research landscape over the coming years.<\/p> As currently, the success of any newly designated AHSCs will require close interplay and cooperation between research infrastructure, including NIHR Biomedical Research Centres (BRCs) and the NIHR ARCs, and with the AHSNs and wider innovation landscape.<\/p> As part of annual monitoring of the existing Department-designated AHSCs, examples of innovations arising from them have been reported to have been made available to patients in the NHS. These include:<\/p> - The King\u2019s Health Partners Heart Failure Service, which brings together clinical, research and educational expertise to deliver world class heart care in south London, helping people with heart failure live longer and with better quality of life;<\/p> - University College London Partners AHSC adoption of a Learning Health System to standardise data entry and allowing the widespread trialling of novel tools to detect atrial fibrillation early;<\/p> - The Manchester AHSC working with partners to align research around core health and social care priorities; and supporting the roll out of a single blood test driven decision-aid for patients presenting with chest pain at local emergency departments; and<\/p> - The roll out of the innovative Sleepio app by the Oxford AHSN to support those suffering from insomnia across Oxfordshire, Berkshire and Buckinghamshire.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
, "dateOfAnswer" : {"_value" : "2019-07-17", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL16931"}
, {"_value" : "HL16934"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-17T16:29:08.223Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Medicine: Research"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what the future relationship will be between Academic Health Science Networks, Academic Health Science Centres and Academic Research Collaborations with regard to the future applied health science ecosystem.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4151", "label" : {"_value" : "Biography information for Lord Willis of Knaresborough"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Willis of Knaresborough"}
], "uin" : "HL16932"}
, {"_about" : "http://data.parliament.uk/resources/1136784", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1136784/answer", "answerText" : {"_value" : " The Department-designated Academic Health Science Centres (AHSCs) along with the Academic Health Science Networks (AHSNs) and the National Institute for Health Research (NIHR) Applied Research Collaborations (ARCs) are all important components of the country\u2019s health research and innovation ecosystem.<\/p> The six current Department-designated AHSCs were made on the basis of an open competition, which was open to eligible National Health Service and University partnerships across England. The recommendations for designation were made to the Department by an international independent panel.<\/p> The remit of the Accelerated Access Collaborative (AAC) has recently been expanded to become the umbrella body across the United Kingdom health innovation eco-system. The AAC has been asked to consider the role of new AHSCs within the health system and to ensure that they complement the innovation landscape, rather than add further complexity to it.<\/p> It is not possible to provide specific details of the scope and nature of the new designation process at this stage given that the AAC is currently actively considering this. However, it is expected that the future designation process would be open to all NHS and University partnerships across England which meet the published specification to apply, including partnerships in areas of England where there is currently no Departmental-AHSC. As with the previous AHSC designation process, any future process will be run via a full and open competition, assessed by an independent expert panel. Rigorous conflict of interest policies will also be in place throughout the process for all involved to ensure any potential conflicts are dealt with appropriately.<\/p> The existing Departmental-AHSC designation will be extended until the end of March 2020 to enable a new designation process to be undertaken. The Department\u2019s expectation is that AHSCs will play an increasingly important role in the health innovation and research landscape over the coming years.<\/p> As currently, the success of any newly designated AHSCs will require close interplay and cooperation between research infrastructure, including NIHR Biomedical Research Centres (BRCs) and the NIHR ARCs, and with the AHSNs and wider innovation landscape.<\/p> As part of annual monitoring of the existing Department-designated AHSCs, examples of innovations arising from them have been reported to have been made available to patients in the NHS. These include:<\/p> - The King\u2019s Health Partners Heart Failure Service, which brings together clinical, research and educational expertise to deliver world class heart care in south London, helping people with heart failure live longer and with better quality of life;<\/p> - University College London Partners AHSC adoption of a Learning Health System to standardise data entry and allowing the widespread trialling of novel tools to detect atrial fibrillation early;<\/p> - The Manchester AHSC working with partners to align research around core health and social care priorities; and supporting the roll out of a single blood test driven decision-aid for patients presenting with chest pain at local emergency departments; and<\/p> - The roll out of the innovative Sleepio app by the Oxford AHSN to support those suffering from insomnia across Oxfordshire, Berkshire and Buckinghamshire.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
}
, "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
, "dateOfAnswer" : {"_value" : "2019-07-17", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "HL16931"}
, {"_value" : "HL16932"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-17T16:29:08.27Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Academic Health Science Networks"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what assessment they have made of whether the innovations arising from the current phase of Academic Health Science Centres are being made available to patients throughout the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4151", "label" : {"_value" : "Biography information for Lord Willis of Knaresborough"}
}
, "tablingMemberPrinted" : [{"_value" : "Lord Willis of Knaresborough"}
], "uin" : "HL16934"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}